Molecular epigenetics and genetics in neuro-oncology

作者: Raman P. Nagarajan , Joseph F. Costello

DOI: 10.1016/J.NURT.2009.04.002

关键词:

摘要: Gliomas arise through genetic and epigenetic alterations of normal brain cells, although the exact cell origin for each glioma subtype is unknown. The alteration-induced changes in gene expression protein function allow uncontrolled division, tumor expansion, infiltration into surrounding parenchyma. are tumor-grade specific. Particular predict aggressiveness, response to therapy, patient survival. Genetic include deletion, gain, amplification, mutation, translocation, which result oncogene activation suppressor inactivation, or some instances may simply be a consequence tumorigenesis. Epigenetic tumors CpG island hypermethylation associated with silencing, gene-specific hypomethylation aberrant activation, genome-wide potentially leading loss imprinting, chromosomal instability, cellular hyperproliferation. Other alterations, such as position histone variants modifications also likely important molecular pathology tumors. Given that deacetylases targets drugs already clinical trial, surprisingly little known about acetylation primary Although majority independent there interaction on specific genes, signaling pathways within domains. Next-generation sequencing technology now method choice genomic epigenome profiling, allowing more comprehensive understanding contributions tumorigenesis brain.

参考文章(148)
K R Ostler, E M Davis, S L Payne, B B Gosalia, J Expósito-Céspedes, M M Le Beau, L A Godley, Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene. ,vol. 26, pp. 5553- 5563 ,(2007) , 10.1038/SJ.ONC.1210351
Sith Sathornsumetee, David A. Reardon, Annick Desjardins, Jennifer A. Quinn, James J. Vredenburgh, Jeremy N. Rich, Molecularly targeted therapy for malignant glioma Cancer. ,vol. 110, pp. 13- 24 ,(2007) , 10.1002/CNCR.22741
Jacquetta M. Trasler, Daphne G. Trasler, Timothy H. Bestor, En Li, Felicia Ghibu, DNA methyltransferase in normal and Dnmtn/Dnmtn mouse embryos. Developmental Dynamics. ,vol. 206, pp. 239- 247 ,(1996) , 10.1002/(SICI)1097-0177(199607)206:3<239::AID-AJA2>3.0.CO;2-J
Yae Kanai, Saori Ushijima, Yukihiro Nakanishi, Michiie Sakamoto, Setsuo Hirohashi, Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Letters. ,vol. 192, pp. 75- 82 ,(2003) , 10.1016/S0304-3835(02)00689-4
Stanton L. Gerson, MGMT: its role in cancer aetiology and cancer therapeutics. Nature Reviews Cancer. ,vol. 4, pp. 296- 307 ,(2004) , 10.1038/NRC1319
Jeongwu Lee, Svetlana Kotliarova, Yuri Kotliarov, Aiguo Li, Qin Su, Nicholas M. Donin, Sandra Pastorino, Benjamin W. Purow, Neil Christopher, Wei Zhang, John K. Park, Howard A. Fine, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. ,vol. 9, pp. 391- 403 ,(2006) , 10.1016/J.CCR.2006.03.030
S. F. Wolf, D. J. Jolly, K. D. Lunnen, T. Friedmann, B. R. Migeon, Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 2806- 2810 ,(1984) , 10.1073/PNAS.81.9.2806
Joseph F. Costello, Christoph Plass, Webster K. Cavenee, Aberrant methylation of genes in low-grade astrocytomas. Brain Tumor Pathology. ,vol. 17, pp. 49- 56 ,(2000) , 10.1007/BF02482735
Ilker Y Eyüpoglu, Eric Hahnen, Rolf Buslei, Florian A Siebzehnrübl, Nicolai E Savaskan, Mike Lüders, Christian Tränkle, Wolfgang Wick, Michael Weller, Rudolf Fahlbusch, Ingmar Blümcke, None, Suberoylanilide hydroxamic acid (SAHA) has potent anti‐glioma properties in vitro, ex vivo and in vivo Journal of Neurochemistry. ,vol. 93, pp. 992- 999 ,(2005) , 10.1111/J.1471-4159.2005.03098.X
Iris Lavon, Daniel Zrihan, Bracha Zelikovitch, Yakov Fellig, Dana Fuchs, Dov Soffer, Tali Siegal, Longitudinal Assessment of Genetic and Epigenetic Markers in Oligodendrogliomas Clinical Cancer Research. ,vol. 13, pp. 1429- 1437 ,(2007) , 10.1158/1078-0432.CCR-06-2050